Melatonin quickly became one of the most widely used sleep aids for children around the world. The main driver of its popularity is the belief that it is a natural and easily accessible solution to insomnia. But new research shows that the rapid increase in its use is outpacing scientific understanding of how safe and effective it actually is for children over the long term.
Melatonin appears to have a clear effect on sleep disturbances in children with neurodevelopmental disorders. However, strong evidence remains limited for children without these disorders. Researchers are also concerned about increased dosage inconsistencies, use without medical supervision, and accidental ingestion of commercially available products. Taken together, these concerns indicate the need for more caution, stronger regulation, and clearer evidence-based guidance when using melatonin to address sleep problems in children.
Why families turn to melatonin
Sleep disorders are becoming increasingly common among children and teens. Lack of sleep can affect emotional regulation, cognitive development, and overall health. As parents seek quick and convenient solutions, melatonin supplements have become widely used because they are readily available, often come in child-friendly forms, and are widely recognized as a safe alternative to prescription drugs.
Despite that perception, melatonin is actually a hormone that affects more than just your sleep cycle. It plays a role in regulating the immune system, metabolism, and reproductive processes. Research on the use of melatonin in children is still uneven. Many studies examine only short-term outcomes or focus on specific clinical populations. Because of these limitations, researchers say there is an urgent need to carefully evaluate the safety, efficacy, and appropriate use of melatonin in pediatric care.
A review examining global melatonin use in children
A narrative review published in World Pediatric Journalresearchers at Boston Children’s Hospital investigated the rapidly increasing use of melatonin among children and adolescents around the world. This review analyzed the clinical evidence related to melatonin’s efficacy, safety profile, and real-world usage patterns.
Researchers found a clear discrepancy between melatonin’s widespread use and the limited amount of long-term scientific data available. The review also highlighted concerns about inappropriate use, inconsistent product quality, and lack of strong regulatory oversight for sleep supplements marketed to children.
Evidence Shows Benefits for Some Children
According to this review, melatonin use in children has increased rapidly over the past decade. This growth is particularly pronounced in countries where supplements are sold over-the-counter.
The short-term benefits of melatonin for children with neurodevelopmental disorders such as autism and attention-deficit hyperactivity disorder are supported by strong clinical evidence. In these cases, melatonin can help children fall asleep faster, increase total sleep time, and improve the overall quality of life for caregivers.
Limited data on neurotypical children
For children without underlying developmental disorders, the situation is less clear. Research in this group is limited and often inconsistent. Most randomized clinical trials are short in duration and focus primarily on older children and teenagers. As a result, researchers cannot draw strong conclusions about younger children, even though melatonin use is becoming more common in that age group.
Long-term safety data are particularly limited. Scientists still have unanswered questions about whether melatonin, when used long-term, may affect puberty, immune function, metabolism, or neurological development.
Safety concerns regarding melatonin products
This review also highlights some safety issues that can occur outside of a controlled clinical setting. Testing of over-the-counter melatonin supplements reveals significant differences between the labeled dosage and the actual amount of melatonin in some products. In some cases, supplements may have contained several times the stated dose or unexpected compounds, such as serotonin.
Data from the Pediatric Poison Control Center also shows a sharp increase in melatonin ingestion among children. Young children appear to be especially vulnerable due to candy-like gummy formulations and improper storage at home. These findings suggest that the risks associated with real-world melatonin use may be higher than previously assumed.
Experts recommend cautious and limited use
Researchers warn that melatonin should not be treated as a quick-fix solution to childhood sleep problems. Although it can be helpful in certain carefully selected situations, especially when supervised by a medical professional, it is not a substitute for a thorough sleep assessment or behavioral intervention.
This review emphasizes that both clinicians and caregivers should view melatonin as a biologically active hormone rather than a harmless supplement. Without stronger evidence and better regulation, routine or unsupervised use may expose children to unnecessary risks while distracting from proven non-pharmacological strategies that support healthy sleep.
Behavioral sleep strategies remain first-line treatment
The results of this study have important implications for pediatric medicine, public health policy, and caregiver education. Behavioral approaches to sleep should continue to be the primary treatment for childhood insomnia. These strategies include maintaining a consistent bedtime routine, limiting screen exposure before bed, and setting age-appropriate sleep expectations.
When using melatonin, this review recommends starting with the lowest effective dose, limiting the duration of treatment, and using it only under medical supervision. The researchers also highlight the need for stronger oversight of melatonin products designed for children, clearer labeling standards, and more long-term clinical studies. These steps will help ensure children receive evidence-based support for safe, effective, and healthy sleep.
